ID

36980

Description

TReatment Of Pulmonary HYpertension 1 Study; ODM derived from: https://clinicaltrials.gov/show/NCT02516722

Link

https://clinicaltrials.gov/show/NCT02516722

Keywords

Versions (1)
  1. 6/26/19 6/26/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 26, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Pulmonary Arterial Hypertension NCT02516722

English

Eligibility Pulmonary Arterial Hypertension NCT02516722

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient with known pulmonary arterial hypertension (pah), which has been diagnosed as idiopathic pah, connective tissue disease pah, anorexogen induced or familial pah
Description

Pulmonary arterial hypertension | Idiopathic pulmonary hypertension | Pulmonary arterial hypertension Associated with Connective Tissue Disease | Pulmonary arterial hypertension Anorexigenic drug Induced | Familial pulmonary hypertension

Data type

boolean

Alias
UMLS CUI [1]
C2973725
UMLS CUI [2]
C0152171
UMLS CUI [3,1]
C2973725
UMLS CUI [3,2]
C0332281
UMLS CUI [3,3]
C0009782
UMLS CUI [4,1]
C2973725
UMLS CUI [4,2]
C0003620
UMLS CUI [4,3]
C0205263
UMLS CUI [5]
C0340543
pah diagnosis confirmed by hemodynamic evaluation performed prior to screening and showing all of the following: mean pulmonary artery pressure (mpap) ≥25 mmhg at rest; pulmonary capillary wedge pressure (pcwp) or left ventricular end diastolic pressure (lvedp) ≤15 mmhg; pulmonary vascular resistance (pvr) at rest >3 wood units; not meeting the criteria for a positive vasodilator response (fall in mpap ≥ 10 mmhg to ≤
Description

Pulmonary arterial hypertension Evaluation Hemodynamic | Mean pulmonary arterial pressure At rest | Pulmonary Capillary Wedge Pressure | Left ventricular end-diastolic pressure level | Pulmonary Vascular Resistance At rest | Criteria failed | Vasodilator Response Positive

Data type

boolean

Alias
UMLS CUI [1,1]
C2973725
UMLS CUI [1,2]
C1261322
UMLS CUI [1,3]
C0019010
UMLS CUI [2,1]
C3854605
UMLS CUI [2,2]
C0443144
UMLS CUI [3]
C0086879
UMLS CUI [4]
C0456190
UMLS CUI [5,1]
C0456261
UMLS CUI [5,2]
C0443144
UMLS CUI [6,1]
C0243161
UMLS CUI [6,2]
C0231175
UMLS CUI [7,1]
C0042402
UMLS CUI [7,2]
C1704632
UMLS CUI [7,3]
C1514241
40 mmhg).
Description

ID.3

Data type

boolean

patient with a current diagnosis of who functional class iii
Description

WHO classification Functional Status Class

Data type

boolean

Alias
UMLS CUI [1,1]
C4267671
UMLS CUI [1,2]
C0598463
UMLS CUI [1,3]
C0456387
patient should be on two pulmonary arterial hypertension specific medications other than parenteral prostanoids
Description

Pulmonary arterial hypertension | Pharmaceutical Preparations Specific Quantity | Exception Prostaglandins Parenteral

Data type

boolean

Alias
UMLS CUI [1]
C2973725
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0205369
UMLS CUI [2,3]
C1265611
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0033554
UMLS CUI [3,3]
C1518896
patient is adhering to a stable drug regimen (i.e., with no changes of dose or medication for a minimum of 3 months prior to enrollment)
Description

Pharmacotherapy Stable | Drug dosage unchanged | Change of medication Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0870450
UMLS CUI [2,2]
C0442739
UMLS CUI [3,1]
C0580105
UMLS CUI [3,2]
C0332197
patient with egfr levels of ≥ 30 ml/min/1.73m2or serum creatinine levels of ˂
Description

Estimated Glomerular Filtration Rate | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C3811844
UMLS CUI [2]
C0201976
150µmol/l
Description

ID.8

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient who are treated with parenteral prostanoids
Description

Prostaglandins Parenteral

Data type

boolean

Alias
UMLS CUI [1,1]
C0033554
UMLS CUI [1,2]
C1518896
pregnant women or women planning a pregnancy within 12 months of study enrolment
Description

Pregnancy | Pregnancy, Planned

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
patient with significant co-morbid conditions which, at the discretion of the pi, are deemed to prohibit study entry
Description

Comorbidity Study Subject Participation Status Excluded

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C0332196
patient with life expectancy of less than a year
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
concurrent enrollment in another device or drug trial except for observational studies (unless specifically approved by the sponsor)
Description

Study Subject Participation Status | Investigational Medical Device | Investigational New Drugs | Exception Observational Study

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C2346570
UMLS CUI [3]
C0013230
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1518527
patient with pulmonary artery anatomy that precludes treatment
Description

Pulmonary artery Anatomic structure Excludes Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C0034052
UMLS CUI [1,2]
C0700276
UMLS CUI [1,3]
C0332196
UMLS CUI [1,4]
C0087111
patient with moderate to severe pulmonary artery stenosis
Description

Pulmonary artery stenosis Moderate | Pulmonary artery stenosis Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0238397
UMLS CUI [1,2]
C0205081
UMLS CUI [2,1]
C0238397
UMLS CUI [2,2]
C0205082
patient with any pulmonary artery aneurysm
Description

Pulmonary artery aneurysm

Data type

boolean

Alias
UMLS CUI [1]
C0155676
patient who has experienced a myocardial infarction, unstable angina pectoris, or a cerebrovascular accident in the previous 6 months
Description

Myocardial Infarction | Angina, Unstable | Cerebrovascular accident

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0038454
Back to the top of the page

Similar models

Eligibility Pulmonary Arterial Hypertension NCT02516722

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Pulmonary arterial hypertension | Idiopathic pulmonary hypertension | Pulmonary arterial hypertension Associated with Connective Tissue Disease | Pulmonary arterial hypertension Anorexigenic drug Induced | Familial pulmonary hypertension
Item
patient with known pulmonary arterial hypertension (pah), which has been diagnosed as idiopathic pah, connective tissue disease pah, anorexogen induced or familial pah
boolean
C2973725 (UMLS CUI [1])
C0152171 (UMLS CUI [2])
C2973725 (UMLS CUI [3,1])
C0332281 (UMLS CUI [3,2])
C0009782 (UMLS CUI [3,3])
C2973725 (UMLS CUI [4,1])
C0003620 (UMLS CUI [4,2])
C0205263 (UMLS CUI [4,3])
C0340543 (UMLS CUI [5])
Pulmonary arterial hypertension Evaluation Hemodynamic | Mean pulmonary arterial pressure At rest | Pulmonary Capillary Wedge Pressure | Left ventricular end-diastolic pressure level | Pulmonary Vascular Resistance At rest | Criteria failed | Vasodilator Response Positive
Item
pah diagnosis confirmed by hemodynamic evaluation performed prior to screening and showing all of the following: mean pulmonary artery pressure (mpap) ≥25 mmhg at rest; pulmonary capillary wedge pressure (pcwp) or left ventricular end diastolic pressure (lvedp) ≤15 mmhg; pulmonary vascular resistance (pvr) at rest >3 wood units; not meeting the criteria for a positive vasodilator response (fall in mpap ≥ 10 mmhg to ≤
boolean
C2973725 (UMLS CUI [1,1])
C1261322 (UMLS CUI [1,2])
C0019010 (UMLS CUI [1,3])
C3854605 (UMLS CUI [2,1])
C0443144 (UMLS CUI [2,2])
C0086879 (UMLS CUI [3])
C0456190 (UMLS CUI [4])
C0456261 (UMLS CUI [5,1])
C0443144 (UMLS CUI [5,2])
C0243161 (UMLS CUI [6,1])
C0231175 (UMLS CUI [6,2])
C0042402 (UMLS CUI [7,1])
C1704632 (UMLS CUI [7,2])
C1514241 (UMLS CUI [7,3])
ID.3
Item
40 mmhg).
boolean
WHO classification Functional Status Class
Item
patient with a current diagnosis of who functional class iii
boolean
C4267671 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
Pulmonary arterial hypertension | Pharmaceutical Preparations Specific Quantity | Exception Prostaglandins Parenteral
Item
patient should be on two pulmonary arterial hypertension specific medications other than parenteral prostanoids
boolean
C2973725 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0205369 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0033554 (UMLS CUI [3,2])
C1518896 (UMLS CUI [3,3])
Pharmacotherapy Stable | Drug dosage unchanged | Change of medication Absent
Item
patient is adhering to a stable drug regimen (i.e., with no changes of dose or medication for a minimum of 3 months prior to enrollment)
boolean
C0013216 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0870450 (UMLS CUI [2,1])
C0442739 (UMLS CUI [2,2])
C0580105 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Estimated Glomerular Filtration Rate | Creatinine measurement, serum
Item
patient with egfr levels of ≥ 30 ml/min/1.73m2or serum creatinine levels of ˂
boolean
C3811844 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
ID.8
Item
150µmol/l
boolean
Item Group
C0680251 (UMLS CUI)
Prostaglandins Parenteral
Item
patient who are treated with parenteral prostanoids
boolean
C0033554 (UMLS CUI [1,1])
C1518896 (UMLS CUI [1,2])
Pregnancy | Pregnancy, Planned
Item
pregnant women or women planning a pregnancy within 12 months of study enrolment
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Comorbidity Study Subject Participation Status Excluded
Item
patient with significant co-morbid conditions which, at the discretion of the pi, are deemed to prohibit study entry
boolean
C0009488 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
Life Expectancy
Item
patient with life expectancy of less than a year
boolean
C0023671 (UMLS CUI [1])
Study Subject Participation Status | Investigational Medical Device | Investigational New Drugs | Exception Observational Study
Item
concurrent enrollment in another device or drug trial except for observational studies (unless specifically approved by the sponsor)
boolean
C2348568 (UMLS CUI [1])
C2346570 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C1518527 (UMLS CUI [4,2])
Pulmonary artery Anatomic structure Excludes Therapeutic procedure
Item
patient with pulmonary artery anatomy that precludes treatment
boolean
C0034052 (UMLS CUI [1,1])
C0700276 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
Pulmonary artery stenosis Moderate | Pulmonary artery stenosis Severe
Item
patient with moderate to severe pulmonary artery stenosis
boolean
C0238397 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C0238397 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Pulmonary artery aneurysm
Item
patient with any pulmonary artery aneurysm
boolean
C0155676 (UMLS CUI [1])
Myocardial Infarction | Angina, Unstable | Cerebrovascular accident
Item
patient who has experienced a myocardial infarction, unstable angina pectoris, or a cerebrovascular accident in the previous 6 months
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial